[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610713":3},{"organization":4,"outcomesModule":7,"designInfo":21,"detailedDescription":20,"studyPopulation":24,"armGroups":25,"interventions":36,"overallOfficials":46,"centralContacts":50,"locations":56,"responsibleParty":71,"collaborators":73,"id":77,"slug":20,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":20,"eligibilityCriteria":81,"healthyVolunteers":82,"sex":83,"minAge":84,"maxAge":20,"enrollmentInfo":85,"targetDuration":88,"studyType":89,"phases":20,"briefSummary":90,"conditions":91,"keywords":20,"overallStatus":59,"whyStopped":20,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"AdventHealth","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":20},[9],{"measure":10,"description":11,"timeFrame":12},"The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance,","Reach will assess the percentage and characteristics of patients screened or excluded, as well as participant versus non-participant profiles.\n\nEffectiveness will measure the proportion of positive screens referred for confirmatory diagnostics and compare screening rates to Healthy People 2030 goals.\n\nAdoption will track provider education on breast, lung, and prostate cancer screening guidelines, uptake of screening practices, and staff engagement with navigation programs.\n\nImplementation will evaluate referrals to navigation, screening rates, and for positive screens: referral time, diagnostic barriers, treatment uptake, and clinical trial screening.\n\nMaintenance will examine primary outcomes at three months, progress toward HP2030 goals, attrition rates, and differences by patient characteristics.","From enrollment to the end of the 3 month follow-up for a total of 12 months",[14,17],{"measure":15,"description":16,"timeFrame":12},"PROMIS Global Health (HR-QoL) scale","A 10-item scale to assess physical, mental, and social health on a scale of 5 (Excellent) to 1 (Poor), ability to carry out everyday activities on a scale of 5 (Completely) to 1 (Not at all), emotional problems on a scale of 5 (Never) to 1 (Always), fatigue on a scale of 5 (None) to 1 (Very severe), and pain on a scale of 0 (No pain) to 10 (Worst imaginable pain)",{"measure":18,"description":19,"timeFrame":12},"Patient Satisfaction with Logistical Aspects of Navigation Scale (PSN-L)","A 26-item scale to assess satisfaction with the navigation program on a scale of 3 (Very satisfied) to 1 (Not Satisfied)",null,{"allocation":20,"interventionModel":20,"interventionModelDescription":20,"primaryPurpose":20,"observationalModel":22,"timePerspective":23,"maskingInfo":20},"COHORT","PROSPECTIVE","Community Resource Spots, Emergency Departments and Urgent Care Centers",[26,31],{"label":27,"type":20,"description":28,"interventionNames":29},"community-based initiative for screening, diagnosis, and treatment of breast, lung, and prostate","Identify differences between adults who accept or decline cancer follow-up diagnosis and treatment, and clinical trial screening Identify barriers and facilitators to cancer screening, diagnosis, treatment, and clinical trial screening Understand perceptions towards navigators in the cancer care continuum",[30],"Behavioral: referral for definitive diagnosis based on their cancer screening results",{"label":32,"type":20,"description":33,"interventionNames":34},"Recruitment of Stakeholder","Investigators will establish relationships with community stakeholders, providers, and other key personnel to inform them of the program, the study, and opportunities to engage in stakeholder focus groups to provide feedback about program operations. For those interested in participating, a study team member will explain the study and the requirements for participation, review the informed consent form in detail, and obtain consent.",[35],"Behavioral: Engagement",[37,42],{"type":38,"name":39,"description":40,"armGroupLabels":41,"otherNames":20},"BEHAVIORAL","referral for definitive diagnosis based on their cancer screening results","Need for radiological diagnosis",[27],{"type":38,"name":43,"description":44,"armGroupLabels":45,"otherNames":20},"Engagement","Engage in stakeholder focus groups to provide feedback about program operations",[32],[47],{"name":48,"affiliation":5,"role":49},"Mark Socinski, MD","PRINCIPAL_INVESTIGATOR",[51],{"name":52,"role":53,"phone":54,"phoneExt":20,"email":55},"Patricia Robinson, PhD","CONTACT","407-303-3286","patricia.robinson@adventhealth.com",[57],{"facility":58,"status":59,"city":60,"state":61,"zip":62,"country":63,"countryCode":64,"cosmosGeoPoint":65,"geoPoint":70,"contacts":20},"Adventhealth","RECRUITING","Orlando","Florida","32804","United States","US",{"type":66,"coordinates":67},"Point",[68,69],-81.37924,28.53834,{"lat":69,"lon":68},{"type":72,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[74],{"name":75,"class":76},"Florida Department of Health","OTHER_GOV","100610713",false,"NCT07231159","Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots","Inclusion Criteria:\n\n1. Adult aged 18 or older\n2. Seeking care at a CRS or emergency department\n3. Meets criteria for lung, breast, and\u002For prostate cancer screening, as outlined below:\n\n   1. Lung cancer: Adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years\n   2. Breast cancer: Women aged 40 to 74 years\n   3. Prostate cancer: Men aged 55 to 69 years\n4. Receives a positive screening result for lung, breast, and\u002For prostate cancer at a study site\n\nExclusion Criteria:\n\n1. Displays behavior disruptive to other patients or staff\n2. Refusal to accept screening for breast, lung, and\u002For prostate cancers",true,"ALL","18 Years",{"count":86,"type":87},200,"ESTIMATED","12 Months","OBSERVATIONAL","To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.",[92,93,94],"Breast Cancer","Lung Cancer (Diagnosis)","Prostate Cancer","2025-11-14",{"date":97,"type":98},"2025-11-17","ACTUAL",{"date":97,"type":87},{"date":101,"type":87},"2026-08-31",{"name":5,"class":6},1]